r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

MH

Michael R. Hayden

Insider · Director · ABCL

Michael R. Hayden files insider transactions with the SEC as a director of AbCellera Biologics (ABCL). We hold 4 disclosed purchases and sales filed since 6 November 2014, 4 of them in the last 90 days.

  • Files forABCL
  • Disclosed buys and sells4 in all, 4 in the last 90 days
  • Last disclosure24 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 November 2020 — 24 August 2026Director · AbCellera Biologics (ABCL)21 Form 4 lines · source: SEC Form 4
  • Filed 20 September 2018 — 31 July 2026Director · Ionis Pharmaceuticals (IONS)47 Form 4 lines · source: SEC Form 4
  • Filed 11 November 2019 — 30 October 2025Director · 89bio (ETNB)33 Form 4 lines · source: SEC Form 4
  • Filed 4 November 2014 — 3 June 2021Director · Xenon Pharmaceuticals (XENE)47 Form 4 lines · source: SEC Form 4
  • Filed 29 January 2021 — 29 January 2021Director · Aurinia Pharmaceuticals (AUPH)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.